Sublingual Misoprostol Versus Oxytocin to Induce Labor in Term premature rupture of membranes pregnancy woman,A Randomized Controlled Trial

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

TCTR

Registry ID

TCTR20200722003

Enrollment

164

Registered

2020-07-22

Start date

2020-07-31

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Enrollment by inclusion criteria and exclusion criteria

Interventions

Sublingual misoprostal 25 micrograms ,Oxytocin intravenous infusion

Active Comparator Drug,Experimental Drug

Misoprostol ,Oxytocin

Eligibility

Sex/Gender

Female

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Singleton pregnancy PROM between 37 -42 weeks of gestation Cephalic presentation History of <5 vaginal delivery Bishops scores < 6

Exclusion criteria

Exclusion criteria: More than uterine contraction in 10 minutes Abnormal fetal heart rate patterns Potential cephalopelvic disproportion (CPD) Fetal anomaly

Design outcomes

Primary

Measure	Time frame
The induction delivery interval 10 months Medical data record	—

Secondary

Measure	Time frame
N/A N/A N/A	—

Countries

Thailand

Contacts

Public ContactSuchada Unthanan

Bhumibol Adulyadej hospital

suchadaeaw@hotmail.com0911975999

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026

Sublingual Misoprostol Versus Oxytocin to Induce Labor in Term premature rupture of membranes pregnancy woman&#44;A Randomized Controlled Trial